CXCL10 and rheumatoid arthritis: Murine and translational studies suggested that CXCR3 and CXCR6 are key elements for effector T cells to migrate into the joints in rheumatoid arthritis, and MDX-1100, anti-CXCL10 monoclonal antibody, showed clinical efficacy in rheumatoid arthritis56,57.